Peter J Wilkinson

CIK 1398138 · SVP, Chief Accounting Officer · last filed 2026-03-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$927.6K

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$3.59M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LH	SVP, Chief Accounting Officer	3,485	$266.16	$927.6K	-$3.29M	37	2026-03-30
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted	VP of Fin./Chief Acctg. Off.	828	—	—	-$299.5K	10	2009-01-05

Recent Filings · Page 2 of 5

47 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-02-10	LH	Mixed	+175	-$22.7K	EDGAR
2024-05-01	LH	Sell (S)	−2,439	-$498.4K	EDGAR
2024-03-29	LH	Mixed	+2,185	-$193.6K	EDGAR
2024-02-13	LH	Mixed	+80	-$9.8K	EDGAR
2024-02-08	LH	Mixed	+88	-$10.3K	EDGAR
2024-02-06	LH	Mixed	+86	-$10.0K	EDGAR
2023-11-20	LH	Sell (S)	−1,384	-$291.6K	EDGAR
2023-08-03	LH	Mixed	+39	-$3.6K	EDGAR
2023-07-05	LH	Grant (A)	—	$0	EDGAR
2023-04-03	LH	Mixed	+1,272	-$118.2K	EDGAR

Showing 11–20 of 47

Prev Page 2 of 5 Next

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.